TDOC Stock Cash Flow Statements

Teladoc Health Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Teladoc Health Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30

cash flows from operating activities:
net income	-32,660,000	-93,012,000	-48,409,000	-33,276,000	-837,671,000	-81,889,000	-28,890,000	-57,073,000	-65,177,000	-69,228,000	-3,810,071,000	-73,476,000	-3,101,461,000	-6,674,523,000	-10,985,000	-84,340,000	-133,819,000	-199,649,000	-393,967,000	-35,884,000	-25,682,000	-29,603,000	-19,044,000	-20,346,000	-29,324,000	-30,150,000	-24,879,000	-23,264,000	-25,079,000	-23,862,000	-44,383,000	-31,330,000	-15,415,000	-15,654,000	-14,261,000	-29,772,000	-14,879,000	-15,304,000	-15,007,000	-13,246,000
adjustments to reconcile net income to net cash flows from operating activities:
goodwill impairment	0	59,138,000	0	0			0	0	0	0	3,772,812,000	0	3,030,000,000	6,600,000,000
amortization of intangible assets	88,664,000	84,304,000	86,540,000	86,906,000	94,862,000	95,057,000
depreciation of property and equipment	4,338,000	3,564,000	2,980,000	2,666,000	1,703,000	2,834,000
amortization of right-of-use assets	1,885,000	2,305,000	2,151,000	2,242,000	2,288,000	2,614,000	3,325,000	2,547,000	2,722,000	3,056,000	2,491,000	2,726,000	3,367,000	3,173,000	3,864,000			2,948,000
benefit from allowances for doubtful accounts	318,000	59,000	1,596,000	1,389,000	724,000	86,000
stock-based compensation	22,344,000	25,163,000	27,472,000	34,047,000	42,107,000	42,325,000	46,823,000	52,964,000	55,725,000	46,038,000	50,754,000	55,662,000	51,000,000	60,436,000	61,615,000	71,701,000	82,970,000	86,300,000	414,380,000	20,908,000	21,928,000	18,315,000	18,457,000	17,354,000	17,368,000	13,523,000	12,683,000	12,195,000	11,059,000	7,832,000	16,969,000	5,966,000	4,565,000	3,097,000			1,634,000	1,288,000	979,000	718,000
deferred income taxes	-7,207,000	-26,865,000	-1,756,000	-757,000	2,968,000	-1,600,000	4,755,000	-3,101,000	-3,202,000	-355,000	-1,898,000	-3,414,000	-209,000	-2,319,000	-49,614,000	7,591,000	-3,181,000	87,004,000	-86,062,000	-639,000	-637,000	-2,820,000	-580,000	-8,816,000	1,200,000	-2,672,000	-340,000	-649,000	-673,000	-585,000	-531,000	-74,000	149,000	150,000	150,000	188,000	10,000	162,000	161,000
other	296,000	1,753,000	4,584,000	2,517,000	1,292,000	1,403,000	-5,561,000	681,000	8,092,000	-3,522,000	3,907,000	413,000	0	3,264,000	-3,883,000	0	0	38,000
changes in operating assets and liabilities:
accounts receivable	6,773,000	-15,270,000	-4,050,000	6,646,000	-5,104,000	2,133,000	-9,556,000	6,336,000	7,014,000	-14,046,000	-16,374,000	-1,319,000	-16,106,000	-27,842,000	1,897,000	-2,834,000	-4,856,000	-11,717,000	-4,641,000	8,323,000	-7,554,000	-17,219,000	-3,498,000	-5,149,000	1,014,000	-8,251,000	-3,396,000	-3,508,000	711,000	-4,738,000	-473,000	-2,000,000	623,000	-1,809,000	-1,385,000	989,000	-42,000	-2,462,000	-3,380,000
prepaid expenses and other current assets	7,352,000	-23,786,000	2,339,000	15,866,000	10,674,000	-23,691,000	-1,609,000	-2,555,000	22,790,000	-6,165,000	-1,904,000	-18,982,000	-1,202,000	-18,993,000	3,476,000	-7,808,000	-13,959,000	-12,799,000	-6,659,000	-7,501,000	1,494,000	101,000	-466,000	-3,470,000	901,000	350,000	-956,000	-1,116,000	-1,139,000	599,000	714,000	-3,417,000	1,130,000	-430,000	290,000	-1,551,000	978,000	-543,000	363,000
inventory	-654,000	1,515,000	-1,421,000	-2,296,000	-2,941,000	-3,091,000	5,849,000	-2,367,000	10,613,000	10,000,000	1,091,000	1,735,000	9,951,000	2,023,000	-16,833,000	-427,000	643,000	-2,877,000	-22,340,000
other assets	7,204,000	412,000	-2,696,000	763,000	-333,000	1,009,000	-4,690,000	-899,000	-7,524,000	-9,939,000	-4,913,000	-5,401,000	-11,406,000	-6,047,000	-115,000	-5,351,000	675,000	1,244,000	-8,275,000	104,000	-101,000	137,000	-178,000	-1,000	44,000	30,000	-87,000	-254,000	-104,000	31,000	187,000	-196,000			-24,000	-6,000			-8,000	-19,000
accounts payable	1,922,000	17,356,000	-4,514,000	-18,465,000	18,484,000	-5,870,000	17,485,000	10,118,000	-22,656,000	-9,132,000	-22,191,000	-23,350,000	46,925,000	492,000	12,303,000	-6,374,000	7,248,000	-11,989,000	-94,579,000	4,740,000	2,346,000	-502,000	2,881,000	-2,350,000	402,000	-28,000	-34,000	-1,728,000	1,904,000	-533,000	2,316,000	303,000	-798,000	-287,000	1,452,000	-558,000	-572,000	-1,135,000	157,000	-4,517,000
accrued expenses and other current liabilities	-17,717,000	12,568,000	16,198,000	13,826,000	-25,031,000	25,185,000	-8,006,000	-3,667,000	5,290,000	15,452,000	-8,829,000	49,334,000	9,006,000	11,706,000	2,295,000	10,500,000	7,269,000	-1,889,000	2,856,000	-7,939,000	3,643,000	21,565,000	-6,171,000	10,654,000	-4,172,000	14,530,000	-3,568,000	7,848,000	-2,123,000	1,836,000	-5,140,000	7,729,000	737,000	966,000	-1,759,000	1,127,000	-2,877,000	1,288,000	2,857,000	-3,466,000
accrued compensation	11,918,000	-21,463,000	15,444,000	9,859,000	6,171,000	-51,973,000	18,747,000	15,965,000	16,733,000	-32,265,000	19,738,000	6,300,000	10,491,000	-48,819,000	12,677,000	18,254,000	8,018,000	-43,624,000	25,490,000	11,147,000	11,980,000	-13,798,000	6,359,000	7,320,000	2,604,000	-11,737,000	6,489,000	5,803,000	4,105,000	-7,917,000	2,801,000	1,231,000	1,657,000	-1,921,000	1,074,000	2,309,000	1,496,000	-3,191,000	371,000	868,000
deferred revenue	-542,000	-5,542,000	-7,790,000	-8,818,000	-8,935,000	7,297,000	-3,639,000	-8,807,000	1,898,000	5,648,000	2,929,000	1,488,000	3,344,000	7,479,000	552,000	2,797,000	119,000	17,086,000	2,403,000
operating lease liabilities	-2,688,000	-2,482,000	-2,804,000	-2,664,000	-2,563,000	-2,861,000	-3,091,000	-2,187,000	-2,088,000	-2,858,000	-3,414,000	-845,000	-3,640,000	-3,626,000	-8,330,000	-2,369,000	-2,757,000	-3,076,000	-1,940,000	-1,572,000	-1,501,000	-1,287,000	-936,000	-687,000	-315,000	-479,000
other liabilities	-114,000	-3,798,000	38,000	-276,000	-12,000	-48,000	-624,000	-36,000	-18,000	129,000	-2,348,000	2,332,000	223,000	-7,000	1,105,000	1,235,000	286,000	-19,000	449,000	-1,962,000	-304,000	-543,000	3,242,000	-214,000	-971,000	-1,414,000	405,000	295,000	-1,002,000	1,047,000	-3,310,000	-1,645,000	1,150,000	495,000	621,000	-596,000	263,000	353,000	-2,476,000	2,598,000
net cash from operating activities	91,432,000	15,919,000	85,902,000	110,175,000	88,683,000	8,920,000	130,082,000	105,601,000	101,182,000	13,156,000	65,549,000	63,021,000	92,469,000	-31,747,000	83,208,000	76,591,000	52,217,000	-18,026,000	-114,936,000			-6,320,000	18,122,000	13,490,000	6,149,000	-7,892,000	2,476,000	10,181,000	-3,646,000	-13,871,000	-7,275,000	-11,745,000	-2,914,000	-12,507,000	-8,045,000	-14,875,000	-11,745,000	-17,130,000	-12,804,000
cash flows from investing activities:
capital expenditures	-1,268,000	-2,726,000	-6,132,000	-1,597,000	-1,912,000	-1,149,000	-1,404,000	-5,793,000	-1,904,000	-2,363,000	-6,195,000	-3,830,000	-2,542,000	-3,913,000	-2,923,000	-1,206,000	-2,290,000	-2,115,000
free cash flows	90,164,000	13,193,000	79,770,000	108,578,000	86,771,000	7,771,000	128,678,000	99,808,000	99,278,000	10,793,000	59,354,000	59,191,000	89,927,000	-35,660,000	80,285,000	75,385,000	49,927,000	-20,141,000
capitalized software development costs	-28,965,000	-28,859,000	-23,512,000	-29,551,000	-25,836,000	-34,363,000										-13,894,000	-10,364,000	-11,144,000
proceeds from the sale of investment											0	0				0
acquisition accounted for as a business combination, net of cash acquired
asset acquisition resulting in net intangible assets
payments for investments	0	-27,075,000
net cash from investing activities	-59,696,000	-123,268,000	-29,644,000	-31,148,000	-27,748,000	-35,512,000	-36,506,000	-37,647,000	-36,570,000	-45,624,000	-53,891,000	-41,448,000	-44,837,000	-27,567,000	-20,075,000	-34,708,000	-2,168,000	-16,030,000	-413,925,000	-155,460,000	-9,662,000	-11,928,000	9,547,000	13,194,000	-5,064,000	7,336,000	-42,348,000	461,000	-239,581,000	23,972,000	8,342,000	-439,860,000	4,128,000	-20,989,000	13,712,000	-11,691,000	12,051,000	12,074,000	14,266,000
cash flows from financing activities:
proceeds from the exercise of stock options	1,000	80,000
proceeds from employee stock purchase plan	695,000	689,000	1,027,000	923,000	1,282,000	1,516,000	1,054,000	3,162,000	2,704,000	2,731,000	3,115,000	1,414,000	-1,708,000	3,680,000	2,814,000	2,965,000	2,383,000	8,648,000	2,249,000	0			1,505,000	0			1,141,000	0			888,000	0
repayment of convertible senior notes
net cash from financing activities	-549,933,000	769,000	2,058,000	698,000	3,805,000	1,751,000	-1,775,000	5,068,000	4,208,000	3,353,000	4,381,000	634,000	-1,334,000	2,816,000	6,625,000	784,000	11,363,000	22,175,000	70,436,000	422,000	773,225,000	15,053,000	10,041,000	9,153,000	5,198,000	10,702,000	7,449,000	341,349,000	284,616,000	12,198,000	-41,463,000	125,403,000	268,062,000	123,429,000	316,000	14,817,000	5,282,000	183,000	-460,000	160,032,000
net increase in cash and cash equivalents			58,316,000	79,725,000			91,801,000	73,022,000			16,039,000	22,207,000			69,758,000	42,667,000			-458,425,000	-122,843,000	799,113,000	-3,195,000	37,710,000	35,837,000	6,283,000	10,146,000	-32,423,000	351,991,000	41,389,000	22,299,000	-40,396,000	-326,202,000	269,276,000	89,933,000	5,983,000	-11,749,000
effect of foreign currency exchange rate changes	4,486,000	1,585,000	-3,855,000	1,758,000	-292,000	-899,000	1,347,000
cash and cash equivalents at beginning of the period	0	1,298,327,000	0	0	0	1,123,675,000	0	0	0	918,182,000	0	0	0	893,480,000	0	0	0	733,324,000	0	0	0	514,353,000	0	0	0	423,989,000	0	0	0	42,817,000	0	0	0	50,015,000	0	0	0	55,066,000
cash and cash equivalents at end of the period	-513,711,000	1,193,332,000	54,461,000	81,483,000	64,448,000	1,097,935,000	93,148,000	71,832,000	70,116,000	888,579,000	18,551,000	18,470,000	44,717,000	836,444,000	69,652,000	40,104,000	63,620,000	720,104,000	-453,975,000	-121,544,000	800,887,000	507,956,000	39,111,000	34,799,000	6,485,000	433,958,000	-33,565,000	351,750,000	40,625,000	65,179,000	-40,302,000	-326,105,000	269,276,000	139,948,000	5,983,000	-11,749,000	5,588,000	50,193,000
cash paid for income taxes			1,712,000	2,621,000
interest paid			8,660,000	0			8,735,000	11,000	8,482,000	194,000	8,673,000	15,000	8,666,000	7,000	8,457,000	1,000	7,969,000	3,000	9,278,000	3,000	5,609,000	0	6,112,000	10,000			6,178,000	0	4,123,000	2,000	4,723,000	2,880,000	853,000	994,000	653,000	684,000	446,000	604,000
supplemental disclosure of non-cash investing activities
accruals related to property and equipment, net and intangible assets	1,410,000	4,271,000	645,000	607,000	-574,000	3,673,000
acquisition of business, net of cash acquired		-64,608,000																					17,000	3,000			45,000	-8,952,000			-1,000				0				0
net decrease in cash and cash equivalents		-106,580,000				-24,841,000				-29,115,000				-56,498,000				-11,881,000																				-4,873,000
cash paid (received) for income taxes		328,000
proceeds from marketable securities							0				0	2,507,000	0	0	0	0	0	50,000,000	2,496,000	0	0	0	12,935,000	16,470,000	13,695,000	9,000,000	4,700,000	11,500,000	42,970,000	25,000,000	39,933,000	26,143,000	4,937,000	14,740,000
net proceeds from the exercise of stock options				34,000	2,546,000	131,000	58,000	746,000	381,000	296,000	238,000	666,000	1,395,000	3,585,000	2,825,000	5,175,000	5,873,000	11,908,000	13,687,000	7,114,000	18,624,000	14,889,000	8,463,000	9,119,000	6,847,000	8,854,000	5,124,000	10,433,000	7,122,000	8,643,000	3,841,000	2,680,000	3,121,000	1,195,000	315,000	1,619,000	94,000	496,000
cash received for withholding taxes on stock-based compensation				-259,000	-23,000	106,000	-2,887,000	1,159,000	954,000	496,000	-470,000	540,000	-49,000	103,000		-2,050,000	3,941,000	1,218,000				164,000
income taxes (refunded) paid						-245,000
depreciation
amortization
depreciation of rental equipment							637,000	641,000	643,000	681,000	674,000	699,000	716,000	770,000	833,000			824,000
benefit from allowances									-5,986,000	9,034,000	6,531,000	3,010,000
accretion of interest							855,000	852,000	848,000	845,000	849,000	837,000	833,000	826,000	14,410,000	14,277,000	15,737,000	16,829,000	15,837,000	12,883,000	9,717,000	6,859,000	6,016,000	7,075,000	6,287,000	6,060,000	5,894,000	5,966,000	4,609,000	3,018,000	3,120,000	3,234,000	46,000	-18,000	233,000	-146,000	46,000	129,000	219,000	160,000
loss on extinguishment of debt											0	0	0	0	21,000	849,000	28,323,000	11,459,000	99,000	1,227,000
gain on sale of investment											0	0	0	0	0	0
capitalized software							-35,103,000	-31,854,000	-34,666,000	-43,261,000	-47,696,000	-39,375,000	-42,295,000	-26,918,000
acquisitions of businesses, net of cash acquired											0	0
income taxes paid							921,000	5,532,000	439,000	346,000	1,611,000	337,000	303,000	261,000	860,000	3,062,000	0	52,000	538,000	727,000	59,000	0	464,000	537,000	286,000	23,000	203,000	179,000	7,000	52,000
depreciation and amortization								94,302,000	75,465,000	69,783,000	75,715,000	62,008,000	59,371,000	58,933,000	52,332,000	51,907,000	51,341,000	48,659,000	31,466,000	15,374,000	11,427,000	11,228,000	11,092,000	11,417,000	10,880,000	11,563,000	9,557,000	9,746,000	8,046,000	8,253,000	7,402,000	6,418,000	2,668,000	2,607,000	2,597,000	2,607,000	1,558,000	1,508,000	1,546,000	1,491,000
foreign exchange difference									1,296,000	-488,000	2,512,000	-3,737,000	-1,581,000	-538,000	-106,000	-2,563,000	2,208,000	-1,339,000	4,450,000	1,299,000	1,774,000	-3,202,000	1,401,000	-1,038,000	202,000	-177,000	-1,142,000	-241,000	-764,000	63,000	94,000
proceeds from advances from financing companies										3,375,000	5,066,000	1,694,000	2,881,000	2,232,000	4,598,000	2,753,000	3,108,000	4,816,000	4,078,000
payment against advances from financing companies										-3,548,000	-3,550,000	-3,681,000	-3,868,000	-3,921,000	-3,997,000

proceeds from issuance of 2027 notes															0	0			0	0
payment of issuance costs of 2027 notes															0	0
repurchase of 2022 notes											0	0	0	0	0	-2,000	-7,000	-130,000	0	-23,000
proceeds from the sale of capped call related to the livongo notes
payment of assumed indebtedness
operating activities:
adjustments to reconcile net income to net cash from operating activities:
investing activities:
financing activities:
benefit from doubtful accounts														4,591,000
acquisitions of business, net of cash acquired														0	-2,719,000	-19,608,000	-415,000	-55,921,000
purchase of software
proceeds from the sale (purchase) of investment
cash received (paid) for withholding taxes on stock-based compensation																				-4,166,000
allowance for doubtful accounts																3,819,000	4,460,000	3,074,000	2,964,000	30,000	1,043,000	1,247,000	948,000	703,000	231,000	783,000	708,000	277,000	110,000	1,148,000	388,000	579,000	458,000	306,000	442,000	541,000	652,000	777,000	616,000	460,000
cash flows used in investing activities:
amortization of right-of-use assets and depreciation of rental equipment
payment from customers against advances from financing companies																	-4,024,000	-4,098,000	-4,208,000
cash flows used in operating activities:
unrealized gain on investment																		-5,852,000
change in fair value of contingent consideration
gain on sale																											0	-1,430,000
purchase of marketable securities																											-44,206,000	0			-29,591,000	-84,716,000	3,000	-34,957,000	41,000	1,000	-7,066,000	-37,122,000	-2,474,000
sale of assets																			0	0	0	0	-10,000	3,000	1,000	6,000	30,000	0
investment in securities																			0	0			0	0
proceeds from issuance of 2025 notes
proceeds from borrowing under bank and other debt																															0				5,500,000	23,990,000			0	0
proceeds from issuance of common stock																											-13,000				134,626,000	0	0	123,928,000	0
cash (paid) received for withholding taxes on stock-based compensation																							73,000
purchase of property and equipment																				-1,231,000	-679,000	-962,000	-663,000	-1,599,000	-677,000	-571,000	-1,279,000	-717,000	-1,458,000	-557,000	-590,000	-744,000	-679,000	-620,000	-990,000	-340,000	-503,000	-275,000	-794,000
purchase of internally-developed software
issuance costs of 2027 notes																				0
net cash from (used) in operating activities
purchase of internal-use software																					-4,483,000	-1,966,000	-2,732,000	-1,683,000	-1,876,000	-1,099,000	-1,638,000	-1,370,000	-917,000	-471,000	-1,409,000	-1,188,000	-133,000	-152,000
pre-funding associated with the pending acquisition																					-4,500,000	-9,000,000
contingent consideration fair value adjustment
amortization of warrants and loss on extinguishment of debt																															12,665,000
proceeds from issuance of convertible notes																											5,000	21,000			0	0
repayment of debt
cash (paid)/received for withholding taxes on stock-based compensation
proceeds from cash received for withholding taxes on stock-based compensation																										1,848,000	1,182,000	39,000	-3,055,000	3,555,000
impairment of long-lived assets
repayment of bank borrowings and other debt
cash for withholding taxes on stock-based awards																															-569,000	235,000	-46,000	306,000
repayment of bank loan and other debt																																-44,191,000	0	-2,000,000	-5,499,000
amortization of warrants																																			0
purchase of internal software																																			-452,000	-194,000	-273,000	-385,000	-368,000
proceeds from the liquidation/maturity of marketable securities																																			15,113,000	25,855,000	19,893,000	49,856,000	17,902,000
proceeds from issuance of convertible preferred stock
proceeds from issuance of common stock under ipo																																							0
repurchase of stock
stock-based compensation, including employee stock purchase plan
payment of deferred offering costs
repayment of bank loan																																					-312,000	-313,000
due from officer																																							0	0
proceeds from the exercise of stock options and warrants																																							102,000	65,000
repayment of bank and other debt																																							-562,000
cash and cash equivalents at beginning of year																																							0	0
cash and cash equivalents at end of year																																							1,002,000	38,641,000
interest paid:																																							627,000	448,000
repayment of term loan

We provide you with 20 years of cash flow statements for Teladoc Health stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Teladoc Health stock. Explore the full financial landscape of Teladoc Health stock with our expertly curated income statements.

The information provided in this report about Teladoc Health stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.